Skip to main content
Back to Shunwei Capital

Shunwei Capital's Biotechnology Portfolio

Browse 6 Biotechnology companies funded by Shunwei Capital. See funding amounts, founder contacts, and investment details.

Biotechnology Companies
6
Total Funding in Biotechnology
$130.4M

Biotechnology Portfolio Companies (6)

Export
BiotechnologyHealth CareMedical

LTZ develops novel immunotherapies to treat patients that suffer from cancer and other diseases with an unmet clinical need.

San Francisco, United States
May 2026
$40.0M
Venture - Series Unknown

Founder Contacts

19,000+ verified contacts

Alternative MedicineArtificial Intelligence (AI)BiotechnologyGeneticsTherapeutics

ReviR Therapeutics is a genomics-based platform that develops novel medicines targeting human RNAs.

Brisbane, United States
April 2026
Corporate Round

Founder Contacts

19,000+ verified contacts

BiotechnologyMedicalMedical Device

Neurodome is a manufacturer of non-invasive deep brain nerve modulation technology and products.

Xian Shi, China
March 2026
$14.5M
Series A

Founder Contacts

19,000+ verified contacts

BiopharmaBiotechnologyHealth CareTherapeutics

VelaVigo is a start-up company engaged in macromolecular biopharmaceutical.

Shanghai, China
July 2025
$60.0M
Seed

Founder Contacts

19,000+ verified contacts

BiotechnologyChemicalManufacturing

Zhihe Bio is a synthetic biology manufacturer of oleochemicals.

Nanjing, China
May 2024
$1.4M
Seed

Founder Contacts

19,000+ verified contacts

Alternative MedicineBiotechnologyMedical

HealiRNA is a ribonucleic acid drug research and development company.

Suzhou, China
March 2023
$14.5M
Seed

Founder Contacts

19,000+ verified contacts

Explore Shunwei Capital's Full Portfolio

View all companies funded by Shunwei Capital across every industry and funding stage.

View Full Shunwei Capital Portfolio